Last reviewed · How we verify

NCT06751160

Comparative Effects of Dry Needling Versus Soft Tissue Mobilization on Hamstring Tightness

Recruiting now NA Last updated 27 December 2024
What this trial tests

NA trial testing Dry Needling in Hamstring Tightness in 30 participants. Currently enrolling.

Timeline
15 July 2024
Primary endpoint
30 December 2024
30 January 2025

Quick facts

Lead sponsorRiphah International University
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment30
Start date15 July 2024
Primary completion30 December 2024
Estimated completion30 January 2025
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Riphah International University

Who can join

Adults 20 to 40, any sex, with Hamstring Tightness or Chronic Low-back Pain. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The hamstring tightness is considered as the inability to achieve knee extension greater than 160 degrees while hip is flexed at 90 degrees. When low back pain (LBP) persists for 12 weeks or longer, it is termed as chronic low back pain. The objective of study is to see the effect of dry needling versus soft tissue mobilization on hamstring muscle on pain, range of motion and functionality in patients with chronic low back pain.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dry Needling

Trials testing the same drug.

Other recruiting trials for Hamstring Tightness

Currently open trials in the same condition.

Other Riphah International University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06751160.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing